The roundtable focused on anticompetitive PBM practices that drive up drug costs for American families, limit patient choice and squeeze community pharmacies.
Next week, on NACDS RxIMPACT Day on Capitol Hill, NACDS members and pharmacy advocates will push for PBM reform in-person to Congress and the Biden Administration.
